Pablo J Cagnoni has an estimated net worth of $30.9 Million. This is based on reported shares across multiple companies, which include Fusion Pharmaceuticals Inc., CRISPR Therapeutics AG, Rubius Therapeutics, Inc., TURMERIC ACQUISITION CORP., INCYTE CORP, ALLOS THERAPEUTICS INC, ONYX PHARMACEUTICALS INC, and OSI PHARMACEUTICALS INC.

2026 was Pablo J Cagnoni's most active year for acquiring shares with 8 total transactions. Pablo J Cagnoni's most active month to acquire stocks was the month of December. 2004 was Pablo J Cagnoni's most active year for disposing of shares, totalling 13 transactions. Pablo J Cagnoni's most active month to dispose stocks was the month of July. 2007 saw Pablo J Cagnoni paying a total of $1,851,000.00 for 375,000 shares, this is the most they've acquired in one year. In 2013 Pablo J Cagnoni cashed out on 50,287 shares for a total of $2,032,125.00, their largest year based on trade value.